期刊文献+

高通量测序鉴定肥厚型心肌病患儿致病突变

Research of identification of pathogenic mutations in hypertrophic cardiomyopathy by high throughput sequencing technique
暂未订购
导出
摘要 目的利用目标基因靶向捕获高通量测序方法鉴定肥厚型心肌病(HCM)患儿的致病突变,分析基因型与临床表型的关系。方法对1例14岁男性HCM患儿进行血液与临床资料收集。提取其全血基因组DNA、文库制备,靶向富集8个编码肌小节蛋白的HCM的致病基因,并行高通量测序。通过生物信息学分析筛选致病突变。用1代测序来验证2代测序发现的致病突变位点。结果患儿有晕厥史,左心室严重肥厚,心电图呈传导阻滞。目标基因捕获高通量测序筛查致病突变的结果经与公共数据库和内部健康人测序数据库对比,发现致病突变位点MYH7R869C。此位点检测结果与Sanger测序结果完全一致。结论利用目标基因捕获测序技术可筛选出HCM致病突变MYH7 R869C。携带此突变的患儿临床表型严重。MYH7 R869C突变可能是我国HCM患儿的突变热点。 Objective To identify pathogenic mutations associated with hypertrophic cardiomyopathy( HCM) in a child by targeted capture and high throughput sequencing technique,and to study the genotype-phenotype correlation. Methods Whole blood and clinical data from a male patient of 14 years old with HCM were collected. Genomic DNA was extracted and library was prepared. Exomes of patients with 8 HCM-related genes encoding sarcomere protein were captured and sequenced. The pathogenic mutation was identified by informatics analysis and was validated by Sanger sequencing technique. Results The patient had the incidence of syncope,severe myocardial hypertrophy in left ventricle and conduction block. Targeted capture and sequencing technique were used to screen the pathogenic mutations associated with HCM. After the results were aligned with public database and in-house database,pathogenic mutations MYH7 R869C was found. The pathogenic mutation was accordant with the result analyzed by Sanger sequencing. Conclusion Pathogenic mutation MYH7 R869C can be identified in HCM by targeted capture and high throughput sequencing technique. The child with the mutation presents severe clinical phenotype. MYH7 R869C mutation might be a hot spot mutation.
出处 《新乡医学院学报》 CAS 2014年第6期423-425,共3页 Journal of Xinxiang Medical University
基金 国家自然科学基金资助项目(编号:81300074)
关键词 心肌病 小儿 突变 目标捕获 高通量测序 cardiomyopathy child mutation targeted capture high throughput sequencing
  • 相关文献

参考文献10

  • 1杨作成.小儿肥厚型心肌病的诊断与治疗[J].中华实用儿科临床杂志,2013,28(1):76-78. 被引量:1
  • 2Ho C Y.Genetics and clinical destiny:improving care in hypertrophic cardiomyopathy[J].Circulation,2010,122(23):2430-2440.
  • 3Gersh B J,Maron B J,Bonow R O,et al.2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy:executive summary:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].Circulation,2011,124(24):2761-2796.
  • 4王绿娅,曹守春,蔺洁,潘晓冬,杜兰平,刘舒,秦彦文,陈保生.降落聚合酶链反应技术在低密度脂蛋白受体基因点突变研究中的应用[J].中华检验医学杂志,2003,26(7):403-406. 被引量:14
  • 5Maron B J,Maron M S.Hypertrophic cardiomyopathy[J].Lancet,2013,381(9862):242-255.
  • 6Morita H,Rehm H L,Menesses A,et al.Shared genetic causes of cardiac hypertrophy in children and adults[J].N Engl J Med,2008,358(18):1899-1908.
  • 7van Driest S L,Jaeger M A,Ommen S R,et al.Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy[J].J Am Coll Cardiol,2004,44(3):602-610.
  • 8Richard P,Charron P,Leclercq C,et al.Homozygotes for a R869C mutation in the beta-myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy[J].J Mol Cell Cardiol,2000,32(8):1575-1583.
  • 9Ng S B,Buckingham K J,Lee C,et al.Exome sequencing identifies the cause of a mendelian disorder[J].Nat Genet,2010,42(1):30-35.
  • 10Rehman A U,Morell R J,Belyantseva I A,et al.Targeted capture and next-generation sequencing identifies C9orf75,encoding taperin,as the mutated gene in nonsyndromic deafness DFNB79[J].Am J Hum Genet,2010,86(3):378-388.

二级参考文献23

  • 1鄢盛恺,周新,哈黛文.聚合酶链反应限制性片段长度多态性检测载脂蛋白E基因型[J].中华医学检验杂志,1997,20(1):28-31. 被引量:60
  • 2陆宗良.脂质代谢异常与冠心病[A].见:陈在嘉主编.临床冠心病学[C].北京:人民军医出版社,1994.61~87.
  • 3Don RH, Coc PT, Wainwright B J, et al. ‘Toughdown' PCR to circumvent spurious priming during gene amplication. Ncleic Acids Res, 1991,19:4008.
  • 4Jensen HK, Jensen LG, Hansen PS, et al. High Sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing. Clin Chem, 1996,42:1140-1146.
  • 5Hecker KH, Roux KH. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR.Biotechniques, 1996,20:478-485.
  • 6Maron BJ,Towbin JA,Thiene G. Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the council on clinical cardiology,heart failure and transplantation committee;Quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups;and council on epidemiology and prevention[J].Circulation,2006,(14):1807-1816.
  • 7Elliott P,Andersson B,Arbustini E. Classification of the cardiomyopathies:a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases[J].European Heart Journal,2008,(02):270-276.
  • 8Gersh B J,Maron B J,Bonow RO. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Developed in collaboration with the American Association for Thoracic Surgery,American Society of Echocardiography,American Society of Nuclear Cardiology,Heart Failure Society of America,Heart Rhythm[J].Journal of the American College of Cardiology,2011,(25):e212-e260.
  • 9Landstrom AP,Ackerman MJ. Beyond the cardiac myofilament:Hypertrophic cardiomyopathy-associated mutations in genes that encode calcium-handling proteins[J].Current Molecular Medicine,2012,(05):507-518.
  • 10Williams LK,Frenneaux MP,Steeds RP. Echocardiography in hypertrophic cardiomyopathy diagnosis,prognosis,and role in management[J].European Journal of Echocardiography,2009,(08):iii9-iii14.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部